Catecholaminergic polymorphic ventricular tachycardia history and symptoms: Difference between revisions
| Line 19: | Line 19: | ||
Patients with Catecholaminergic polymorphic ventricular tachycardia may have a positive family history of: | Patients with Catecholaminergic polymorphic ventricular tachycardia may have a positive family history of: | ||
*[[ | *[[Sudden cardiac arrest]] | ||
*[[ | *[[Sudden cardiac death]] | ||
*[[CPVT]] | *[[CPVT]] | ||
Revision as of 10:21, 23 July 2020
|
Catecholaminergic polymorphic ventricular tachycardia Microchapters |
|
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Catecholaminergic polymorphic ventricular tachycardia history and symptoms On the Web |
|
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia history and symptoms |
|
FDA on Catecholaminergic polymorphic ventricular tachycardia history and symptoms |
|
CDC on Catecholaminergic polymorphic ventricular tachycardia history and symptoms |
|
Catecholaminergic polymorphic ventricular tachycardia history and symptoms in the news |
|
Blogs on Catecholaminergic polymorphic ventricular tachycardia history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The majority of patients with [disease name] are asymptomatic.
OR
The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
History and Symptoms
- Clinical presentation of Catecholaminergic polymorphic ventricular tachycardia is variable, including asymptomatic patients identified as a part of familial screening.
History
Patients with Catecholaminergic polymorphic ventricular tachycardia may have a positive history of:
- Syncope during exercise or emotion
- Sudden cardiac arrest
Patients with Catecholaminergic polymorphic ventricular tachycardia may have a positive family history of:
Common Symptoms
Common symptoms of catecholaminergic polymorphic ventricular tachycardia include:
- Syncope triggered by exercise or emotion[1][2][3]
- Sudden cardiac death during exercise or emotional stress[2][4][5]
Less Common Symptoms
Less common symptoms of catecholaminergic polymorphic ventricular tachycardia include
References
- ↑ Leenhardt, Antoine; Lucet, Vincent; Denjoy, Isabelle; Grau, Francis; Ngoc, Dien Do; Coumel, Philippe (1995). "Catecholaminergic Polymorphic Ventricular Tachycardia in Children". Circulation. 91 (5): 1512–1519. doi:10.1161/01.CIR.91.5.1512. ISSN 0009-7322.
- ↑ 2.0 2.1 Priori, Silvia G.; Napolitano, Carlo; Memmi, Mirella; Colombi, Barbara; Drago, Fabrizio; Gasparini, Maurizio; DeSimone, Luciano; Coltorti, Fernando; Bloise, Raffaella; Keegan, Roberto; Cruz Filho, Fernando E.S.; Vignati, Gabriele; Benatar, Abraham; DeLogu, Angelica (2002). "Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation. 106 (1): 69–74. doi:10.1161/01.CIR.0000020013.73106.D8. ISSN 0009-7322.
- ↑ Napolitano, Carlo (May 2007). "Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia" (PDF). Heart Rhythm. 4 (5): 675–8. doi:10.1016/j.hrthm.2006.12.048. PMID 17467641. Retrieved 2008-12-17. Unknown parameter
|coauthors=ignored (help)[dead link] - ↑ Tester, David J.; Spoon, Daniel B.; Valdivia, Hector H.; Makielski, Jonathan C.; Ackerman, Michael J. (2004). "Targeted Mutational Analysis of the RyR2-Encoded Cardiac Ryanodine Receptor in Sudden Unexplained Death: A Molecular Autopsy of 49 Medical Examiner/Coroner's Cases". Mayo Clinic Proceedings. 79 (11): 1380–1384. doi:10.4065/79.11.1380. ISSN 0025-6196.
- ↑ Sumitomo, N (2003). "Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death". Heart. 89 (1): 66–70. doi:10.1136/heart.89.1.66. ISSN 0007-0769.